文献速递腹部技术与安全US

H扫描、剪切波与生物发光评估胰腺癌肝转移进展

H-scan, Shear Wave and Bioluminescent Assessment of the Progression of Pancreatic Cancer Metastases in the Liver.
PubMed 文献 · Ultrasound Med Biol · 2020-09-06

本研究对转移性胰腺癌小鼠模型重复行经腹超声,应用剪切波和H扫描散射分析,并以生物发光为替代参考;三种方法测值均随时间增加,化疗组延迟;H扫描与生物发光相关性较强,Spearman秩相关系数全序列大于0.7。

要点

  • H扫描测值变化与生物发光测量密切同步,尤其在肿瘤早中期。
  • 剪切波速度、H扫描和生物发光测值均随肿瘤生长呈上升趋势。
  • 化疗组上述测值随时间的上升较未治疗组延迟。

诊断标准与关键数值

  • H扫描与生物发光的Spearman秩相关系数全序列大于0.7。
  • 肿瘤转移灶生长侵袭性强,未治疗约4周死亡,化疗组生存更长。

局限性

  • 原文称这些结果为初步结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The non-invasive quantification of tumor burden and the response to therapies remain an important objective for imaging modalities. To characterize the performance of two newly optimized ultrasound-based analyses, we applied shear wave and H-scan scattering analyses to repeated trans-abdominal ultrasound scans of a murine model of metastatic pancreatic cancer. In addition, bioluminescence measurements were obtained as an alternative reference. The tumor metastases grow aggressively and result in death at approximately 4 wk if untreated, but longer for those treated with chemotherapy. We found that our three imaging methods (shear wave speed, H-scan, bioluminescence) trended toward increasing output measures with time during tumor growth, and these measures were delayed for the group receiving chemotherapy. The relative sensitivity of H-scan tracked closely with bioluminescence measurements, particularly in the early to mid-stages of tumor growth. The correlation between H-scan and bioluminescence was found to be strong, with a Spearman's rank correlation coefficient greater than 0.7 across the entire series. These preliminary results suggest that non-invasive ultrasound imaging analyses are capable of tracking the response of tumor models to therapeutic agents.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Baek J, Ahmed R, Ye J, et al. H-scan, Shear Wave and Bioluminescent Assessment of the Progression of Pancreatic Cancer Metastases in the Liver. Ultrasound Med Biol. 2020. PMID: 32907773. doi:10.1016/j.ultrasmedbio.2020.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。